BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 3038124)

  • 1. Calmodulin-stimulated plasma membrane (Ca2+ + Mg2+)-ATPase: inhibition by calcium channel entry blockers.
    Raess BU; Gersten MH
    Biochem Pharmacol; 1987 Aug; 36(15):2455-9. PubMed ID: 3038124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verapamil, diltiazem and nifedipine interactions with calmodulin stimulated (Ca2+ + Mg2+)-ATPase.
    Kim HC; Raess BU
    Biochem Pharmacol; 1988 Mar; 37(5):917-20. PubMed ID: 2964236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of erythrocyte Ca2(+)-pump by Ca2+ antagonists.
    Raess BU; Record DM
    Biochem Pharmacol; 1990 Dec; 40(11):2549-55. PubMed ID: 2148481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of berbamine derivatives on activated Ca2+-stimulated Mg2+-dependent ATPase in erythrocyte membranes.
    Xu YH; Liu J; Zhang SP; Liu LH
    Biochem J; 1987 Dec; 248(3):985-8. PubMed ID: 2963623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium channel blockers inhibit the (Ca2+ + Mg2+)-ATPase activity and the 125I-calmodulin binding in brain membranes.
    Santos DL; Lopes MC; Carvalho CM
    Eur J Pharmacol; 1994 May; 267(3):307-16. PubMed ID: 8088369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action of long-chain fatty acids in vitro on Ca2+-stimulatable, Mg2+-dependent ATPase activity in human red cell membranes.
    Davis FB; Davis PJ; Blas SD; Schoenl M
    Biochem J; 1987 Dec; 248(2):511-6. PubMed ID: 2963620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of erythrocyte membrane Ca(2+)-pumping ATPase of hypertensive humans by nifedipine, a calcium entry blocker.
    Olorunsogo OO; Onatola OO; Lawal SO; Bababunmi EA; Falase AO; Okunade WG
    Afr J Med Med Sci; 1991 Mar; 20(1):61-5. PubMed ID: 1829316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of calmodulin-stimulated (Ca2+ + Mg2+)-ATPase activity by dimethyl sulfoxide.
    McConnell EJ; Wagoner MJ; Keenan CE; Raess BU
    Biochem Pharmacol; 1999 Jan; 57(1):39-44. PubMed ID: 9920283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of trifluoperazine, compound 48/80, TMB-8 and verapamil on the rate of calmodulin binding to erythrocyte Ca2+-ATPase.
    Scharff O; Foder B
    Biochim Biophys Acta; 1984 Apr; 772(1):29-36. PubMed ID: 6231956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel blocker inhibition of the calmodulin-dependent effects of thyroid hormone and milrinone on rabbit myocardial membrane Ca2+-ATPase activity.
    Warnick PR; Davis FB; Mylotte KM; Davis PJ; Dube MP; Blas SD
    Biochem Pharmacol; 1988 Jul; 37(13):2619-23. PubMed ID: 2968801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of calmodulin on the interaction of carbodiimides with the purified human erythrocyte (Ca2+ + Mg2+)-ATPase.
    Olorunsogo OO; Villalobo A; Wang KK; Roufogalis BD
    Biochim Biophys Acta; 1988 Nov; 945(1):33-40. PubMed ID: 2972318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further characterization of the membrane-bound (Ca2+ + Mg2+)-ATPase from porcine erythrocytes.
    Bewaji CO; Bababunmi EA
    Int J Biochem; 1987; 19(8):721-4. PubMed ID: 2957253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular dichroism and fluorescence studies on interaction of calmodulin (CaM) with purified (Ca2(+)-Mg2+)ATPase of erythrocyte ghosts.
    Wrzosek A; Famulski KS; Pikuła S
    Acta Biochim Pol; 1990; 37(1):173-6. PubMed ID: 2150904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of apparent calmodulin affinity of erythrocyte (Ca2+ + Mg2+)-ATPase at low Ca2+ concentrations.
    Foder B; Scharff O
    Biochim Biophys Acta; 1981 Dec; 649(2):367-76. PubMed ID: 6119113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational changes of (Ca2+-Mg2+)-ATPase of erythrocyte plasma membrane caused by calmodulin and phosphatidylserine as revealed by circular dichroism and fluorescence studies.
    Wrzosek A; Famulski KS; Lehotsky J; Pikuła S
    Biochim Biophys Acta; 1989 Nov; 986(2):263-70. PubMed ID: 2531612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of basal and calmodulin-activated Ca2+-pump ATPase by fractionated compound 48/80.
    Di Julio D; Hinds TR; Vincenzi FF
    Biochim Biophys Acta; 1989 Jun; 981(2):337-42. PubMed ID: 2525052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high-affinity, calmodulin-sensitive (Ca2+ + Mg2+)-ATPase and associated calcium-transport pump in the Ehrlich ascites tumor cell plasma membrane.
    Klaven NB; Pershadsingh HA; Henius GV; Laris PC; Long JW; McDonald JM
    Arch Biochem Biophys; 1983 Oct; 226(2):618-28. PubMed ID: 6139089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purified (Ca2+-Mg2+)-ATPase of the erythrocyte membrane. Reconstitution and effect of calmodulin and phospholipids.
    Niggli V; Adunyah ES; Penniston JT; Carafoli E
    J Biol Chem; 1981 Jan; 256(1):395-401. PubMed ID: 6108953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A calmodulin-stimulated Ca2+ pump in plasma-membrane vesicles from Trypanosoma brucei; selective inhibition by pentamidine.
    Benaim G; Lopez-Estraño C; Docampo R; Moreno SN
    Biochem J; 1993 Dec; 296 ( Pt 3)(Pt 3):759-63. PubMed ID: 8280074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Method for the preparation of human erythrocyte membrane with low basal calcium ATPase, responsive to stimulation.
    Thaker JH
    Anal Biochem; 1985 Jan; 144(1):94-7. PubMed ID: 2984958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.